Hardman & Co Research | WebDisclosure

Basculer en Français

8295	Companies
114846	Keywords
55288	Articles
62438	Press releases

Headlines Articles Press releases Hardman & Co Research

Home
Companies
Hardman & Co Research

BRIEF

published on 11/12/2024 at 13:20, 8 days 22 hours ago

ICG Enterprise Trust Shows Strong Growth and Resilience

Investment Strategy ICG Enterprise Trust Résilience Shareholder Returns EBITDA Growth
PRESS RELEASE

published on 11/12/2024 at 13:15, 8 days 22 hours ago

Hardman & Co Q&A on ICG Enterprise Trust (ICGT): Operating companies’ widening margins and strong EBITDA growth
Hardman & Co Research provides Q&A session on ICG Enterprise Trust focusing on widening margins and strong EBITDA growth. Analyst Mark Thomas discusses key topics and Trust's performance

ICG Enterprise Trust Investment Hardman & Co EBITDA Growth Mark Thomas
BRIEF

published on 11/12/2024 at 11:38, 9 days ago

EDX Medical présentera ses résultats au Forum des investisseurs de Hardman & Co

Webinaire Diagnostic Médical Stratégies De Croissance Forum Des Investisseurs EDX Medical
BRIEF

published on 11/12/2024 at 11:38, 9 days ago

EDX Medical to Present at Hardman & Co Investor Forum

Webinar Growth Strategies Medical Diagnostics Investor Forum EDX Medical
PRESS RELEASE

published on 11/12/2024 at 11:33, 9 days ago

Hardman & Co Video Event: EDX Medical (EDX) Investor Forum
Hardman & Co Research presents an upcoming Investor Forum featuring EDX Medical (EDX) at 3:00pm on Thursday, 14 November 2024. Register to join an interactive session discussing medical diagnostics and growth strategies

Hardman & Co Research Growth Strategies Medical Diagnostics Investor Forum EDX Medical
BRIEF

published on 11/11/2024 at 15:05, 9 days 20 hours ago

Shield Therapeutics to Present at Hardman & Co Investor Forum

Sales Growth Online Event Shield Therapeutics Accrufer® Investor Forum
BRIEF

published on 11/11/2024 at 15:05, 9 days 20 hours ago

Shield Therapeutics fera une présentation au Forum des investisseurs de Hardman & Co

Croissance Des Ventes Accrufer® Thérapeutique Shield Événement En Ligne Forum Des Investisseurs
PRESS RELEASE

published on 11/11/2024 at 15:00, 9 days 20 hours ago

Hardman & Co Video Event: Shield Therapeutics (STX) Investor Forum
Hardman & Co to host Shield Therapeutics (STX) Investor Forum on 14 Nov 2024. Register for insights into growth strategies and market leverage opportunities

Hardman & Co Growth Strategies Shield Therapeutics Investor Forum Market Leverage
BRIEF

published on 11/11/2024 at 14:15, 9 days 21 hours ago

Insight into Polar Capital Technology Trust with Hardman Talks

Investment Strategies Market Insights Polar Capital Discounted Shares Technology Investing
BRIEF

published on 11/11/2024 at 14:15, 9 days 21 hours ago

Un aperçu de Polar Capital Technology Trust avec Hardman Talks

Stratégies D'investissement Investissement Dans La Technologie Capitale Polaire Informations Sur Le Marché Actions À Prix Réduit

Accesswire

Published on 11/21/2024 at 10:03, 1 hour 37 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 40 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 40 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 5 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 11 hours 15 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:01, 39 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 40 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 43 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 10 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 1 hour 35 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 42 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 42 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 32 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 20 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE